Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2256 stock hub

HKG/2256 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HKG/2256is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
8.4B
Hong Kong Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
HKG/2256
In the news

Latest news · HKG/2256

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11.7P50 18.9P75 41.4
Trailing P/E118.9
P25 10.7P50 17.9P75 38.5
ROE2.8
P25 -14.7P50 2P75 9.4
ROIC10.4
P25 -10.4P50 1.9P75 10.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HKG/2256 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
194
Groups with data
11
Currency
CNY
Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Cayman Islands
Country code
HK
Employees
226
Employees Change
-55%
Employees Change Percent
-19.57
Enterprise value
HKD 6.4B
Exchange
Hong Kong Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Biotechnology
Isin
KYG0028A1085
Last refreshed
2026-05-10
Market cap
HKD 8.4B
Price
HKD 11.7
Price currency
HKD
Sector
Healthcare
Sic
2836
Symbol
hkg/2256
Website
https://www.abbisko.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
0.73%
EV Earnings
103.84x
EV/EBIT
205.59x
EV/EBITDA
120.93x
EV/FCF
75.57x
EV/Sales
9.37x
FCF yield
1.01%
P/B ratio
3.92x
P/E ratio
118.88x
P/S ratio
12.31x
PE Ratio3 Y
133.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
4.56%
EBITDA Margin
6.28%
FCF margin
12.4%
Gross margin
100%
Gross Profit
HKD 681.2M
Gross Profit Growth
-1.09%
Gross Profit Growth3 Y
7.17%
Gross Profit Growth5 Y
100.14%
Net Income
HKD 61.5M
Net Income Growth
95.21%
Net Income Growth Quarters
2%
Net Income Growth Years
4%
Pretax Margin
19.03%
Profit Margin
9.03%
Profitable Years
2
ROA
0.78
Roa5y
-7.63
ROCE
1.45
ROE
2.85
Roe5y
-57.78
ROIC
10.43
Roic5y
-82,950.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

10
MetricValue
Cagr1y
58.16%
Cagr3y
61.24%
EPS Growth
121.1
EPS Growth Quarters
2
EPS Growth Years
4
Revenue Growth
21.45x
Revenue Growth Quarters
2x
Revenue Growth Years
2x
Revenue Growth3 Y
7.17x
Revenue Growth5 Y
100.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
HKD 0.27
Assets
HKD 2.6B
Cash
HKD 2.3B
Current Assets
HKD 2.4B
Current Liabilities
HKD 491.8M
Debt
HKD 337.7M
Debt EBITDA
HKD 6.4
Debt Equity
HKD 0.16
Debt FCF
HKD 4
Equity
HKD 2.1B
Interest Coverage
8.37
Liabilities
HKD 478.8M
Long Term Assets
HKD 168.9M
Long Term Liabilities
HKD -13M
Net Cash
HKD 2B
Net Cash By Market Cap
HKD 23.84
Net Cash Growth
-7.19%
Net Debt EBITDA
HKD -46.74
Net Debt Equity
HKD -0.93
Net Debt FCF
HKD -23.66
Tangible Book Value
HKD 2.1B
Tangible Book Value Per Share
HKD 3.18
WACC
10.78

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
4.98
Net Working Capital
HKD -110.2M
Quick ratio
4.95
Working Capital
HKD 1.9B
Working Capital Turnover
HKD 0.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
1.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
58.11%
200-day SMA
14.04
3Y total return
319.36%
50-day SMA
12.65
50-day SMA vs 200-day SMA
50under200
All Time High
19.78
All Time High Change
-40.85%
All Time High Date
2025-10-08
All Time Low
2.05
All Time Low Change
470.73%
All Time Low Date
2024-02-15
ATR
0.75
Beta
1.26
Beta1y
1.31
Beta2y
1.07
Ch YTD
-10.07
High
12.33
High52
19.78
High52 Date
2025-10-08
High52ch
-40.85%
Low
11.62
Low52
7.07
Low52 Date
2025-05-12
Low52ch
65.49%
Ma50ch
-7.49%
Price vs 200-day SMA
-16.68%
RSI
36.73
RSI Monthly
56.1
RSI Weekly
41.82
Sharpe ratio
0.95x
Sortino ratio
1.64
Total Return
1.51%
Tr YTD
-10.07
Tr1m
-11.76%
Tr1w
-7.8%
Tr3m
-7.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
HKD 31.1M
Operating Income Growth
-67.24
Operating margin
4.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
461,092,961%
Net Borrowing
324,023,356.7
Shares Insiders
15.97%
Shares Institutions
23.1%
Shares Out
716,461,350
Shares Qo Q
0.27%
Shares Yo Y
-1.51%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
HKD 48.2M
Average Volume
1,787,886.5x
Bv Per Share
3.18
CAPEX
HKD -3.8M
Ch1m
-11.76
Ch1w
-7.8
Ch1y
58.11
Ch3m
-7.44
Ch3y
319.4
Ch6m
-17.37
Change
-5.19%
Change From Open
-5.11
Close
12.34
Days Gap
-0.08
Depreciation Amortization
12,114,443.3
Dollar Volume
30,911,400
Earnings Date
2026-05-11
EBIT
HKD 31.1M
EBITDA
HKD 42.8M
EPS
HKD 0.1
F Score
5
FCF
HKD 84.5M
FCF EV Yield
1.32x
FCF Per Share
HKD 0.12
Financing CF
207,969,769
Fiscal Year End
December
Founded
2,016
Graham Number
2.6547
Graham Upside
-77.31
Income Tax
HKD 68.1M
Investing CF
235,851,230
Is Primary Listing
1
Last Earnings Date
2026-03-02
Last Report Date
2025-12-31
Ma150
13.83
Ma150ch
-15.43%
Ma20
13.17
Ma20ch
-11.18%
Net CF
511,309,602
Next Earnings Date
2026-05-11
Open
12.33
P FCF Ratio
99.23
P OCF Ratio
95.01
Position In Range
11.27
Ppne
37,216,214.7
Price Date
2026-05-08
Price EBITDA
HKD 196
Ptbv Ratio
3.93
Relative Volume
1.57x
Revenue
681,172,296x
SBC By Revenue
5.33x
Share Based Comp
36,286,517
Tax By Revenue
10x
Tax Rate
52.56%
Tr6m
-17.37%
Volume
2,642,000
Z Score
8.09
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HKG/2256 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2256 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+58.1%
S&P 500 1Y: n/a
3Y total return
+319.4%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns HKG/2256?

Insider, institutional, and short-interest positioning.

Institutional ownership
+23.1%
Share of float held by funds and institutions
Insider ownership
+16.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-1.5%
Negative means the company is buying back shares.
Technical

HKG/2256 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
36.7
Neutral momentum band
Price vs 200-day MA
-16.7%
50/200-day relationship not available
Beta (5Y)
1.26
More volatile than the market
Sharpe ratio
0.95
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HKG/2256

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2256 stock rating?

hkg/2256 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2256 analysis?

The full report lives at /stocks/hkg/2256/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2256?

The latest report frames hkg/2256 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2256 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.